We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ODTC market cap is 5.78T. The company's latest EPS is USD 0.1902 and P/E is 5.89.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -114.93M | -127.43M | -68.49M | -3.92M | -817k |
| Net Income | -111.83M | -126.35M | -68.32M | 42.94M | 7.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 188.83M | 167.89M | 79M | 103.73M | 110.45M |
| Total Liabilities | 26.53M | 31.74M | 19.73M | 2.88M | 2.33M |
| Total Equity | 162.3M | 136.15M | 59.26M | 100.85M | 108.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -96.64M | -113.13M | -75.73M | 1.8M | 8.74M |
| Investing | -166k | -432k | -26k | -58.35M | 20.15M |
| Financing | 138.68M | 90.37M | -12.75M | -1.62M | -196k |
| Market Cap | 5.78T |
| Price to Earnings Ratio | 5.89 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.09 |
| Price to Book Ratio | 0.4 |
| Dividend Yield | - |
| Shares Outstanding | 38.51M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 11.18% |
| 52 Week High | 297,280.00 |
| 52 Week Low | 22,796.00 |
| Spread (Intraday) | 150k (100%) |
| Company Name | Odonate Inc (PK) |
| Address |
112 north curry street carson city, nevada |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
